Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular membranes and associated lipids constitute the fundamental structural boundaries of all living cells, composed primarily of a phospholipid bilayer interspersed with proteins, cholesterol, and glycolipids. Beyond providing a physical barrier, these membranes are dynamic platforms for signal transduction, molecular transport, and energy metabolism (Nature Reviews Molecular Cell Biology, 2008). In pharmacology, the membrane itself serves as a critical therapeutic target, particularly for anti-infective agents that exploit differences between host and pathogen lipid compositions. For example, polyene antifungals like Amphotericin B bind to ergosterol to create lethal pores, while lipopeptide antibiotics like daptomycin disrupt bacterial membrane potential (StatPearls, 2023). However, targeting membranes presents significant challenges due to the potential for off-target effects on human cell membranes, often leading to narrow therapeutic windows and toxicities such as nephrotoxicity or hemolysis. Emerging research into membrane lipid therapy also explores modulating membrane fluidity and lipid microdomains, such as lipid rafts, to treat cancer and neurodegenerative disorders by altering the environment of membrane-bound signaling proteins (Escribá et al., 2015). This approach shifts the focus from targeting individual proteins to managing the physical and chemical properties of the lipid environment in which those proteins function.
Drugs targeting cellular membranes typically act by binding to specific lipid components, such as ergosterol in fungi or lipopolysaccharides and phosphatidylglycerol in bacteria, leading to pore formation, membrane depolarization, or physical disruption of the bilayer integrity (StatPearls, 2023; PubMed, PMC4620638). This loss of barrier function results in the rapid leakage of essential intracellular ions (like potassium) and metabolites, ultimately causing cell death.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membranes and associated lipids (N/A).